ASSESSMENT, INTERVENTION AND MEASUREMENT (AIM) The Assessment, Intervention and Measurement (AIM) facility is the only shared resource at MD Anderson that provides expertise in the science of collecting and managing patient-reported outcome data, assessing energy balance, and developing and implementing technology applications for behavioral assessment and intervention.
AIM i s a merger of the former CCSG core, Patient-Reported Outcomes, Survey and Population Research (PROSPR), and the CCSG Developing core, e-Health Technology (EHT). Consolidation of these two resources provided a more cost-efficient and integrated population research core facility.
AIM i s led by Dr. Susan Peterson (director), a professor in the Department of Behavioral Science, and Dr. Karen Basen-Engquist (co-director), a professor in the Department of Behavioral Science and the director of the Center for Energy Balance Research in Cancer Prevention and Survivorship. In the past 6 years, services have been provided to 105 center members in all 16 CCSG programs. Utilization of services provided by the AIM facility has increased 60% since grant Yr37 with 20% of the increase from the former PROSPR facility. Usage has diversified over the past 6 years with an increased number of users from clinical and translational CCSG programs. Peer review-funded usage accounted for 96% of AIM's total usage in Yr42; non-peer review funding accounted for 4% of its usage. In the past year, services have been provided to 36 center members in 12 of 16 CCSG programs with a similar fraction of peer- reviewed usage over the 6-year period. Population science programs accounted for 39% of AIM's usage, and clinical-translational CCSG programs' combined usage accounted for 50% of AIM's total usage. Current CCSG support accounts for 24% ($236,054) of the operating budget, chargebacks account for 45% ($441,576), and institutional support accounts for 31% ($306,914). In Yr44, AIM is requesting $278,346 (32%) in CCSG funding.
AIM has provided support for 75 publications since the previous grant period; 14 (19%) were in journals with IF >5.
The Specific Aims are:
Aim 1. To provide expertise in the science of collecting and managing patient- reported outcome data, including that collected with surveys, web applications, and mobile applications.
Aim 2. To provide expertise in energy balance research, including the assessment of diet, physical activity, and physical functioning, and in the delivery of physical activity interventions.
Aim 3. To provide expertise in the development and implementation of mobile, web, and sensor applications for behavioral assessment and intervention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-43
Application #
9794664
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Taylor, Alison M; Shih, Juliann; Ha, Gavin et al. (2018) Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell 33:676-689.e3
Golemis, Erica A; Scheet, Paul; Beck, Tim N et al. (2018) Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev 32:868-902
Jabbour, Elias; DerSarkissian, Maral; Duh, Mei Sheng et al. (2018) Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 18:257-265
Pataer, Apar; Shao, Ruping; Correa, Arlene M et al. (2018) Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy. Cancer Med 7:2405-2414
Short, Nicholas J; Kantarjian, Hagop; Ravandi, Farhad et al. (2018) A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia. Leuk Lymphoma 59:813-820
Shank, Brandon R; Deaver, Melissa; Baker, Angela et al. (2018) Interdisciplinary implementation of tacrolimus intravenous standard concentration in hematopoietic stem cell transplantation recipients. J Oncol Pharm Pract 24:365-370
Keung, Emily Z; Chiang, Yi-Ju; Voss, Rachel K et al. (2018) Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol 44:170-177
Wang, Jue; Zhao, Wei; Guo, Huifang et al. (2018) AKT isoform-specific expression and activation across cancer lineages. BMC Cancer 18:742
Lu, Zhongming; Sturgis, Erich M; Zhu, Lijun et al. (2018) Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx. Mol Carcinog 57:361-369
Murray, Thomas A; Yuan, Ying; Thall, Peter F et al. (2018) A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups. Biometrics 74:1095-1103

Showing the most recent 10 out of 12418 publications